general intro slide presentation - oxford academic …...medicines optimisation - mr boo vadher 9....
TRANSCRIPT
![Page 1: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/1.jpg)
Introduction Chief Executive Officer: Professor Gary Ford, CBE Chief Operating Officer: Dr Paul Durrands
![Page 2: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/2.jpg)
AHSN core purpose – health and wealth
• Licensed by NHS England for 5 years to deliver four
objectives:
• Focus on the needs of patients and local populations:
support and work in partnership with commissioners and
public health bodies to identify and address unmet health and
social care needs, whilst promoting health equality and best
practice.
• Speed up adoption of innovation into practice to improve
clinical outcomes and patient experience - support the
identification and more rapid uptake and spread of research
evidence and innovation at pace and scale to improve patient
care and local population health.
• Build a culture of partnership and collaboration: promote
inclusivity, partnership and collaboration to consider and
address local, regional and national priorities.
• Create wealth through co-development, testing, evaluation
and early adoption and spread of new products and services.
![Page 3: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/3.jpg)
The Oxford AHSN
• Our Vision. Best health for our population and prosperity for our region
• Our Mission. We will support collaboration, research and innovation across the NHS, universities and business, building on our strengths to deliver exemplary care and create the strongest life science cluster
![Page 4: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/4.jpg)
The Oxford AHSN • Strategy and objectives. Our strategy is to be facilitative and
work through our partners
• We will build infrastructure and support the development of people to accelerate innovation and early adoption in our NHS partners that improves health and adds value
• This will include funding clinical networks and developing teams for commercial development and innovation adoption to promote and accelerate change
• Our values. We will be inclusive, transparent and fair
![Page 5: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/5.jpg)
What and where
Oxford AHSN – 1 of 15 in England
3.3M population
Annual NHS spend circa £5bn
NHS employees 65,000
12 Clinical Commissioning Groups
4 Local Enterprise Partnerships
12 Councils
Major international companies
569 healthcare and life science
organisations
Complex and varied landscape
http://www.oxfordahsn.org/our-work/wealth-creation/obn-map/
Oxford AHSN Life Sciences map link:
![Page 6: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/6.jpg)
Our healthcare, academic and LEP partners 11. South Central Ambulance Service FT 11
![Page 7: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/7.jpg)
New partnerships
Universities
Life Science
Industry
Wealth Creation
Clinical Innovation
Adoption
Research &
Development
Interaction between NHS and universities was not
strong – AHSNs are addressing this
Patients
and Public
Best Care
![Page 8: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/8.jpg)
INVENTION EVALUATION ADOPTION DIFFUSION
NIHR
Infrastructure
BRCs, BRUs, CRFs
NIHR
Infrastructure
CLAHRCs
AHSCs AHSNs
NHS
Patient Care
NHS
Patient Care
NIHR
Infrastructure
Clinical Research Network
NIHR
Programmes
MRC
Programmes
AHSNs, AHSCs and the
Research and Innovation Landscape
![Page 9: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/9.jpg)
Oxford AHSN Governance Structure
Programme Office
Oxford AHSN Board – Nigel Keen (Chair), Gary Ford (CEO) and Paul Durrands (COO) and oversight group chairs
Joe
Harrison
OSG
Best Care
Programme
Clinical
Networks
Jonathan
Michael
OSG
R & D
Programme
Projects
Nick
Edwards
OSG
Wealth
Creation
Programme
Projects
Stuart
Bell CBE
OSG
Informatics
Theme
Projects
Justin
Wilson
OSG
PPIEE
Theme
Projects
AHSN Partnership
Council (annual general meeting open to all)
AHSN Partnership
Board (all NHS CEOs, HEI Leads, LEPs, CCGs,
HETV, SCN, ABPI, ABHI
3 meetings per year)
Anne
Eden
OSG
Clinical
Innovation
Adoption
Projects
We welcome new partners
Great Western Hospitals (NHS) FT is working with our clinical networks, R&D network and
Clinical Innovation Adoption programmes. Bedford Hospitals is working with Imaging Network
and has EBH Fellowship. Frimley Park is engaged in Clinical Innovation Adoption programme.
![Page 10: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/10.jpg)
Oxford AHSN Core Team Structure
CEO Gary Ford
Chair Nigel Keen
COO Paul Durrands
Executive Assistant
Pam Munnelly
Programme Officer
Amy Shearman
PPIEE Sian Rees
Informatics Mike Denis
Wealth Creation
Nick Scott-Ram MBE
R&D (Gary Ford)
Programme and Theme Senior Responsible Officers Best Care
Chandi Ratnatunga
Interim
Programme Director
Simon Hay
Senior Project Manager –
Clinical Networks Will Pank
Commercial Development
Manager Buckinghamshire
/Bedfordshire Nicki Bromwich
Commercial Development
Manager Berkshire
Hugh Penfold
Project Manager
TBC
Director of Corporate
Affairs Megan
Turmezei
Head of Communications
Martin Leaver
Finance Manager
Paul Foster
(through OUH)
Innovation Adoption Manager Sue Ikin
Innovation Adoption Manager
Dominic Balchin
Informatics Lead
Simon Pizzey
Communications and Informatics Administrator
Rochelle Nelson
Implementation Manager
Sarah Pyne
Innovation and Wealth
Administrator Lauren Davis
Procurement Contracts
IT
(Provided by OUHT)
Clinical Innovation Adoption
Tracey Marriott
Clinical Engagement
Lead Katie James
![Page 11: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/11.jpg)
The Oxford AHSN – 4 programmes • Best Care programme
• 10 AHSN funded clinical networks and working with Thames Valley Strategic Clinical Networks
• Continuous learning – working with Health Education Thames Valley
• Evidence Based Healthcare Fellowships
• Patient Safety Academy (and Patient Safety Collaborative)
• Clinical Innovation Adoption programme – adoption at scale of innovations to improve patient outcomes, experience and safety. Clinically led, working with NHS providers and industry
• Research and Development programme - work with Thames Valley and South Midlands Local CRN, NIHR, CLAHRC, life science industry and other research infrastructure
• Wealth Creation programme - to help the region become the favoured location for inward life science investment, life science business creation and growth
![Page 12: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/12.jpg)
Best Care The Oxford AHSN is funding and supporting ten clinical networks for driving improvements in health. We also work closely with the Thames Valley Strategic Clinical Networks (SCN).
1. Children - Prof Andrew Pollard 2. Dementia - Dr Rupert McShane 3. Depression and anxiety - Prof David Clark 4. Diabetes - Prof Stephen Gough/Dr Katharine Owen 5. Early intervention in mental health - Dr Belinda Lennox 6. Imaging - Prof Fergus Gleeson 7. Maternity - Mr Lawrence Impey 8. Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care - Dr Daniel Lasserson 11. Cancer SCN – Dr Bernadette Lavery 12. Cardiovascular SCN – Dr Will Orr
Mr Chandi Ratnatunga, Associate Medical Director at Oxford University Hospitals NHS Trust, is the Senior Responsible Office for the Best Care Programme. He has been involved in the Oxford AHSN since June 2012, working on the development of clinical networks, a unique feature of the Oxford AHSN.
![Page 13: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/13.jpg)
Clinical Network /
Programme / Theme
Host Lead PIDs (Projects)
Anxiety & Depression
Clinical Network
Oxford Health NHS FT Prof David Clark • Reduction in unwarranted variation
• IAPT service development
• Pathfinder IAPT projects
Children’s Clinical
Network
Oxford University Hospitals
NHS Trust
Prof Andrew Pollard • e-Clinics
• Improve immunisation coverage
• Reduce variation in care (Practice
Educator)
• Research facilitation
Co-morbidity Clinical
Network
Oxford University Hospitals
NHS Trust
Prof Mike Sharpe • Reduce variation in care
Dementia Clinical
Network
Oxford Health NHS FT Dr Rupert McShane • ΔG™ Nutraceutical
• Reduce variation in care
• Neighbourhood return
• Data capture systems
Diabetes Clinical
Network
Oxford University Hospitals
NHS Trust
Dr Katharine Owen • Islet cell transplantation
• Tackling variation in diabetes care
• Gestational diabetes telehealth
• Young adult diabetes
Early Intervention
Clinical Network
Oxford Health NHS FT Dr Belinda Lennox / Dr
Mark Allsopp
• Reduce variation in care
• Research recruitment
• Enhancing care continuity and
extending the model of early
intervention
• Common assessment
Imaging Clinical Network Oxford University Hospitals
NHS Trust
Prof Fergus Gleeson • Creation of Radiology on-call /
specialist opinion network
• Imaging trial development and
delivery
• Early PET-CT in Lung Cancer
• Audit of multi-provider imaging
services
![Page 14: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/14.jpg)
Clinical Network /
Programme / Theme
Host Lead PIDs (Projects)
Maternity Clinical
Network
Oxford University Hospitals
NHS Trust
Mr Lawrence Impey • Improving Fetal Medicine care and
consistency
• Maternity information sharing
Medicines Optimisation
Clinical Network
Oxford University Hospitals
NHS Trust
Mr Bhulesh Vadher • Reduction in unwarranted variation
• QIPP and waste reduction projects
• Provision of medicines information
knowledge on discharge
• Develop strategic relationship with
Pharmaceutical Industry partners
Out of Hospital Clinical
Network
Oxford University Hospitals
NHS Trust
Dr Daniel Lasserson • Improving & expanding Out of
Hospital Care models for acute
illness in frail patients
EBHC MSc Fellowship
Programme
University of Oxford Prof Carl Heneghan • Evidence Based Healthcare MSc
Fellowship Programme
Patient Safety Academy University of Oxford Prof Peter McCulloch
Dr Helen Higham
• Development of programmes in
Mental Health & Primary Care
• Training for Trust management staff
• Establishment of the PSA
• Training for Surgical teams
Sustainability Centre for Sustainable
Healthcare
Ms Rachel Stancliffe • Frugal Innovation Fund bid
• Introduce sustainable practice to
everyday considerations
![Page 15: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/15.jpg)
Best Care Oversight Group • Joe Harrison, CEO, Milton Keynes Hospital, Chair • Chandi Ratnatunga, Associate Medical Director, Oxford University Hospitals, Senior
Responsible Owner (SRO) • Tina Kenny Medical Director, Buckinghamshire Healthcare. Medical Lead • Nursing Leads: Catherine Stoddart, Chief Nurse Designate, Oxford University Hospitals
and Helen McKenzie, Director of Nursing, Berkshire Healthcare • David Buckle, Medical Director, NHS Central Southern CSU and Annette Gamel, Chief
Clinical Officer, Chiltern CCG, Clinical Sciences Lead/Allied Healthcare Commissioning Leads
• Sir John Muir Gray, Public Health Lead • Jim Davis, Professor of Software Engineering, University of Oxford, Informatics Lead • Angela Coulter, Senior Research Scientist - Health Services Research Unit,
Independent Advisor • Nigel Edwards CEO, Nuffield Trust, Independent Advisor • Jennifer Dixon (to be confirmed) CEO Health Foundation, Independent Advisor • Paul Durrands COO, Oxford AHSN, Senior Business Lead • Will Pank Best Care Programme Manager, Oxford AHSN
![Page 16: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/16.jpg)
Clinical Networks tackle variation • Significant variation in diagnosis, treatment and health outcomes (eg amputations)
across Oxfordshire
• Our clinical networks are tackling variation, eg in fetal health and diagnosis and treatment of young people with diabetes
![Page 17: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/17.jpg)
Monster Manor - helping children manage their diabetes
![Page 18: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/18.jpg)
Healthy babies for mothers with diabetes – self management
Dr Lucy Mackillop
Prof Tarassenko
![Page 19: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/19.jpg)
Clinical Innovation Adoption The Clinical Innovation Adoption programme has evaluated around 200 innovations taking account of potential benefits, impact on patient experience, local priorities and ease of implementation. A final shortlist of ten, drawn from various sources including the Oxford AHSN clinical networks, local providers, national awards and National Institute for Health and Care Excellence (NICE) Technology Appraisal (TA) recommendations – were approved by the Oxford AHSN Board and are being adopted across our region in 2014/15.
Tracey Marriott, Director of Clinical Innovation Adoption/ Tracey is leading the Clinical Innovation Adoption Programme for the Oxford AHSN, working closely with the Oxford AHSN clinical networks, providers, commissioners and suppliers for innovation implementation.
![Page 20: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/20.jpg)
Higher
Priority
Medium
Priority
Lower
Priority
Review of Oxford AHSN Region NHS Strategic Priorities
Source: NHS Providers Strategic Plans, NHS CCGs Strategic Plans, Joint Strategic Needs
Assessments for Oxfordshire, Buckinghamshire, Berkshire and Bedfordshire
![Page 21: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/21.jpg)
Review of Oxford AHSN Region NHS Strategic Priorities
![Page 22: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/22.jpg)
Clinical Innovation Adoption Ten Innovations for 2014/15
1. CAUTI bladder scanner – reduce urinary tract infections
2. ECG Monitor - moving care closer to home
3. Electronic blood transfusion – patient safety and waste reduction
4. Intermittent pneumatic compression stockings – reduce risk of stroke
5. SHaRON (adults with eating disorders) – better clinical engagement and experience
6. NICE TA - Alzheimer's – improved patient outcome and carer experience
7. NICE TA - Rheumatoid arthritis – improved patient outcome and experience
8. NICE TA - AF, warfarin, anticoagulants - reduce risk of stroke
9. NICE TA - Renal cancer - improved survival
10. Intra operative fluid management - patient safety and recovery
![Page 23: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/23.jpg)
Clinical Innovation Adoption Oversight Group Role Name Title
Chair Anne Eden CEO – Buckinghamshire Health
Senior Responsible Owner (SRO) Best Care Chandi Ratnatunga Consultant Cardiothoracic Surgeon – Oxford University Hospitals
CIA Programme Director Tracey Marriott Director of Clinical Innovation Adoption – Oxford AHSN
Senior Business Lead Paul Durrands Chief Operating Officer – Oxford AHSN
Provider Medical Director Brian Reid Mr Brian Reid – Medical Director – Royal Berkshire Hospital
Provider Director of Nursing Catherine Stoddart Director of Nursing – Oxford University Hospitals
Provider Director of Finance Alex Gild Director of Finance – Berkshire Healthcare
Provider Procurement lead Wayne Preston Director of Finance and Procurement – Buckinghamshire Health
Provider Chief Operating Officer Lisa Glynn Chief Operating Officer – Heatherwood & Wexham Park Hospitals
Commissioner Finance lead Janet Meek Director of Finance, Berkshire West CCG Federation
Commissioner Contract Lead Rebakah Punter Director of Contracting & Procurement Central Southern CSU
Academic Lead Clinical Nursing Practice Susan Procter Clinical Nursing Lead, Buckinghamshire New University
Academic Lead Diagnostics & Primary Care Carl Heneghan Professor and Director of Centre for Evidence Based Medicine, University of Oxford. Also Co-Director Diagnostic Evaluation Collaborative
Academic Lead Innovation Adoption Clive Savory Open University – Communications & System Department
Academic Lead Patient Safety Charles Vincent Professor of Psychology – Department of Experimental Psychology
Oxford AHSN Medicines Optimisation Network Lead
Bhulesh Vadher Chief Pharmacist – Oxford University Hospitals
Senior Lecturer Marketing and Course – Leader PR & MarCom
Bill Nichols Director – Centre for Health Communications Research Buckinghamshire New University
![Page 24: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/24.jpg)
Prof Gary A Ford CBE is Chief Executive Officer of the Oxford AHSN. Gary has led the adoption of innovation in stroke care for many years. He remains a practising clinician as a Consultant Stroke Physician at Oxford University Hospitals NHS Trust. He is also Director of the National Institute for Health Research (NIHR) Stroke Research Network.
• Brought together leads from Universities and NHS partners
• NHS partners to each develop R&D strategies
• Grow commercial research base and income across the NHS Trusts
• Close links with Clinical Research Network (LCRN) and the Collaboration for Leadership in Applied Health Research and Care (CLAHRC)
• Cross working with the Oxford Academic Health Science Centre (AHSC) – one of 6 leaders in research
Research & Development
![Page 25: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/25.jpg)
Big Data: Delivering the Digital Medicine
Revolution
Building Novel NHS, University
and Industry Relationships
Modulating Immune
Response for Patient Benefit
Managing the Epidemic of
Chronic Disease
Emerging Infections &
Antimicrobial Resistance
Cognitive Health:
Maintaining Cognitive
Function in Health and
Disease
AHSC priorities
Oxford Academic Health Science
Centre - world leading
research in healthcare and life
sciences
![Page 26: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/26.jpg)
Research and Development Oversight Group
University Research lead/alternate
Chairman Sir Jonathan Michael University of Oxford Professor Alastair Buchan
University of Reading Dr Ben Whalley Buckinghamshire New University Professor Susan Procter The Open University Dr Nacho Romero / Dr Claire Turner The University of West London Professor Heather Loveday/Dr Jennie Wilson
Oxford Brookes University Professor Linda King (Mary Boulton/Helen Dawes) University of Buckingham Professor Mike Cawthorne
University of Bedfordshire Professor Mike Cook/ Professor Mike Fisher Cranfield University TBC
Oxford University Hospitals Prof Keith Channon
Oxford Health Prof John Geddes Berkshire Healthcare Dr Justin Wilson Heatherwood and Wexham Park Dr Rob Loveland
Royal Berkshire Dr Atul Kapila South Central Ambulance Service Mr Will Hancock/John Black
Central and North West London Dr Alex Lewis Milton Keynes Mr Martin Wetherill Great Western Dr David Collins Buckinghamshire Healthcare Dr Matthew Burn Bedford Hospital Dr Colette Marshall Southern Health Dr Helen McCormack Health Education Thames Valley/Oxford University Clinical Academic Graduate School
Professor Chris Pugh
South Midland and Thames Valley Clinical Research Network Dr Belinda Lennox
Collaboration for Leadership in Applied Health Research Professor Richard Hobbs/Dr Belinda Lennox
![Page 27: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/27.jpg)
Wealth Creation
Dr Nick Scott-Ram MBE, Director of Commercial Development, has over 25 years experience in commercial and business development in the life sciences sector. Nick was awarded the MBE for services to biotechnology in 2001.
The Wealth Creation Programme will help the region become the favoured location for life science investment, life science business creation and growth, helping the NHS – through the Oxford AHSN’s Clinical Networks – to accelerate the adoption of proven innovations which will bring significant benefit to patients. The Oxford AHSN wealth creation strategy is for, and on behalf of, our member organisations – the NHS, Local Enterprise Partnerships (LEPs), Universities and industry – and the population who all share an interest in economic growth across the region.
![Page 28: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/28.jpg)
Oxford AHSN Wealth Creation
Types of Medical Innovation Any new product or service that delivers benefit to patients
• Pharmaceuticals – New drugs or new uses for established drugs
• Vaccines
• ATMP (Advanced Therapy Medicinal Products) – Gene or cell therapies
• Tissue engineered products and regenerative medicine
• Surgical innovations
• Medical diagnostics and devices
• Information Technology, medical informatics, mHealth and eHealth
• Clinical decision making and support including IT tools to support compliance with best practice
• Healthcare delivery, management and administration
• Health promotion & disease prevention and patient driven wellness (public health)
Outbound Innovation
Helping to ensure that great ideas from
the NHS, universities and industry are
converted into products and services
that create value for patients within and
beyond our region
Inbound Innovation
Informing the NHS about high value
innovations and enabling staff to make
full use of them to improve outcomes
and experiences of patients
![Page 29: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/29.jpg)
Wealth Creation Initiatives in Oxford AHSN region
• The Structural Genomics Consortium • Open access partnerships with the pharmaceutical industry
• The Oxford BioEscalator • Facilitating new models for business growth
• Target Discovery Institute • Link genomics, cell and chemical biology for improved drug discovery
• Centre of Excellence in Personalised Healthcare • Institute of Biomedical Engineering
• University of Reading Science and Innovation Park • £50 million investment in site infrastructure and Phase I
• Phase I – 150,000 – 200,000 sq.ft.
![Page 30: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/30.jpg)
Wealth Creation - create a system to support key stakeholders
• Large companies • Helping identify opportunities for joint working / acquisitions of start ups
• Helping them engage with the NHS
• Innovators / entrepreneurs • Need to know how to get started, how to get help, how to get funding
• Many of these will be from University / NHS
• SBRI working with the other AHSNs
• Helping them engage with the NHS
• Investors • Facilitating the search for investments within the areas of interest
• Improved information provision and "marketing" of investment opportunities in the region
• Experienced entrepreneurs / business people • Connecting with, investing in and supporting start-ups in the region
• Infrastructure providers (LEPs, Isis & others) • Recognising what is needed from them and ensuring that have aligned strategies for
investment
![Page 31: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/31.jpg)
Wealth Creation - building alignment
Category Benefit
Academia Innovation commercialisation and adoption
Clinicians Improved industry engagement and innovation commercialisation
Industry Improved engagement with clinicians, academics, providers; opportunities to commercialise and improved innovation adoption
Patients & Public Improved engagement with clinicians and providers and opportunities to participate in research
Providers Improved engagement with academics and industry
![Page 32: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/32.jpg)
Wealth Creation - benefits for industry
• Better engagement with clinicians, providers and patients / public • Builds a clearer understanding of clinical, provider & patient behaviours
• Improved approach to adoption, by providers, of innovation at scale • Adoption and methods of care assessed in a systemic fashion across the system rather
than by top down imposition or ad hoc local adoption
• Understanding of large strategic changes • Shift to out of hospital care, integrated care
• Opportunities to work with innovators to commercialise their innovations
• New technologies can act as catalyst for change across care pathways which leads to patient benefit
![Page 33: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/33.jpg)
Wealth Creation - emerging themes • Exploring new opportunities for investment vehicles within the region
• MedTech and e-health
• Building a culture of innovation in the NHS • Supporting entrepreneurship – boot camp • Challenge 2023 • Clinical consultancy for businesses • Sustainability – opportunity assessment for HEIs and Trusts on carbon reduction
• Building sustainable businesses that can grow to significant mid-cap opportunities
• Exploring new types of multi-party agreements that enhance co-operation, increase probability of success within a pre-competitive and competitive environment
• Structural Genomics Consortium – disease specific late stage development • University of Reading – flavonoids and improvement of cognition
• Ensuring that the NHS can deliver in terms of innovation adoption, thereby supporting new innovative businesses – key dependency on the Clinical Innovation Adoption programme
![Page 34: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/34.jpg)
Wealth Creation - Apps and e-health Lab • Commissioned App Development Roadmap
• Oxford e-health Lab – multi-partner coordinating hub for e-health activity and acceleration of innovation and implementation
• Local App examples: • AED Locator (find a defibrillator)
• Foodswitch – calorie and salt control
• Monster Manor – blood sugar control for children with Type 1 Diabetes
![Page 35: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/35.jpg)
Wealth Creation - Oversight Group is aligned to the LEPs
Wealth Creation Oversight Group
Berkshire Working Group for Wealth
Creation
Buckinghamshire Working Group for
Wealth Creation
Oxfordshire Working Group for
Wealth Creation
![Page 36: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/36.jpg)
Wealth Creation Oversight Group Role Name Title
Chair Dr Nicholas Edwards Chairman MedInnovate
Internal Dr Nick Scott-Ram MBE Director of Commercial Development – Oxford AHSN
Internal Professor Chas Bountra Professor of Translational Medicine, Head of Structural Genomics Consortium
External Dr Martino Picardo Chief Executive Officer – Stevenage Bioscience Catalyst
External Dr John Collins Chief Operating Officer and Technology Implementation Director – Center for Integration of Medicine and Innovative Technology (CIMIT, Boston, Mass)
External Mr Joel Haspel (Invited) Oracle
External Berkshire Working Group Chair (1)
TBA
External Buckinghamshire Working Group Chair
TBA
External Oxfordshire Working Group Chair
TBA
(1) The working groups have been aligned to the Local Enterprise Partnership geographies to better support inward investment
![Page 37: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/37.jpg)
Informatics
Mike Denis, Director of Information Strategy and Governance, has a dual role across the Oxford AHSN and Oxford AHSC and provides strategic leadership in linking core business goals through informatics and technology innovation, whilst providing critical contribution to the Oxford AHSN and Oxford AHSC partners’ strategies Informatics is a cross-cutting theme, linking core business goals through technology innovation, both within the Oxford AHSN and with partner organisations Informatics map out requirements and establish a common information sharing agreement. We help to facilitate patient recruitment to research studies and clinical trials and extend programme research databases across organisations in primary, community and acute services
Mike Denis, Director of Information Strategy, has over 26 years experience working in NHS health informatics. He previously held a similar role at the South London and Maudsley NHS Foundation Trust.
![Page 38: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/38.jpg)
Patient and Public Involvement, Engagement
and Experience (PPIEE)
Dr Sian Rees is the lead for Patient and Public Involvement, Engagement and Experience, working with colleagues in Trusts across the Oxford AHSN area, and the NHS England Area Team, Health Education Thames Valley and the CLAHRC. In particular, she will support this area of activity in each of the developing clinical networks.
The Oxford AHSN is working to embed partnership with patients and the public across its work programmes. Each of the clinical networks is developing plans for PPIEE. PPIEE Theme is a joint production with the Thames Valley Local Area team and Health Education Thames Valley
What do we mean by involvement? How patients and the public will be involved in the structures and processes of the work i.e though mechanisms such as governance, priority setting, teaching and education, identification of the need for innovation, assessment of technologies. What do we mean by engagement? How patients and their carers will be supported to be active participants in their own care through approaches such as personalised care planning and shared decision-making. What do we mean by experience? How the subjective experience of patients is captured and utilised for quality improvement.
![Page 39: General intro slide presentation - Oxford Academic …...Medicines optimisation - Mr Boo Vadher 9. Mental and physical comorbidity - Prof Michael Sharpe 10. Out of Hospital Care -](https://reader033.vdocuments.us/reader033/viewer/2022060420/5f176a5325cb6d2e0f7e3df0/html5/thumbnails/39.jpg)
Contact details: Megan Turmezei
Director of Corporate Affairs
Oxford AHSN
John Eccles House
Robert Robinson Avenue
OXFORD SCIENCE PARK
OX4 4GP
T: 01865 338425
M: 07837 401519
www.Oxfordahsn.org
Newsletter: http://www.oxfordahsn.org/news-and-
events/network-newsletters/
Annual report: http://www.oxfordahsn.org/wp-
content/uploads/2014/06/Oxford_AH
SN_Annual_Report_2014.pdf